haloperidol has been researched along with Fibrosis in 5 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrosis is a hallmark in the pathogenesis of various diseases, with very limited therapeutic solutions." | 1.51 | High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. ( Battini, T; Braga, L; Carloni, P; Celsi, F; Collesi, C; Confalonieri, M; Crovella, S; Del Sal, G; Giacca, M; Guarnaccia, C; Kocijan, T; Long, C; Marcello, A; Martinelli, V; Myers, MP; Raspa, M; Rehman, M; Ring, N; Rossetti, G; Skoko, N; Vodret, S; Vukusic, K; Zacchigna, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehman, M | 1 |
| Vodret, S | 1 |
| Braga, L | 1 |
| Guarnaccia, C | 1 |
| Celsi, F | 1 |
| Rossetti, G | 1 |
| Martinelli, V | 1 |
| Battini, T | 1 |
| Long, C | 1 |
| Vukusic, K | 1 |
| Kocijan, T | 1 |
| Collesi, C | 1 |
| Ring, N | 1 |
| Skoko, N | 1 |
| Giacca, M | 1 |
| Del Sal, G | 1 |
| Confalonieri, M | 1 |
| Raspa, M | 1 |
| Marcello, A | 1 |
| Myers, MP | 1 |
| Crovella, S | 1 |
| Carloni, P | 1 |
| Zacchigna, S | 1 |
| Tavares, CO | 1 |
| Böttcher, DE | 1 |
| Assmann, E | 1 |
| Kopper, PM | 1 |
| de Figueiredo, JA | 1 |
| Grecca, FS | 2 |
| Scarparo, RK | 2 |
| Haddad, D | 1 |
| Acasigua, GA | 1 |
| Fossati, AC | 1 |
| Fachin, EV | 1 |
| Giovanini, AF | 1 |
| Leonardi, DP | 1 |
| Baratto-Filho, F | 1 |
| Vlença, PC | 1 |
| Moresca, RC | 1 |
| Moro, A | 1 |
| Schramm, CA | 1 |
| Figueiredo, JA | 1 |
| Pesce, HF | 1 |
| Gioso, MA | 1 |
| Figueiredo, MA | 1 |
5 other studies available for haloperidol and Fibrosis
| Article | Year |
|---|---|
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation.
Topics: Actins; Animals; Calcium; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Drug Reposi | 2019 |
Tissue reactions to a new mineral trioxide aggregate-containing endodontic sealer.
Topics: Abscess; Aluminum Compounds; Animals; Biocompatible Materials; Calcium Compounds; Collagen; Drug Com | 2013 |
Mineral trioxide aggregate-based sealer: analysis of tissue reactions to a new endodontic material.
Topics: Abscess; Aluminum Compounds; Animals; Biocompatible Materials; Calcium Compounds; Collagen; Connecti | 2010 |
An endodontic sealer induces a pathological condition when associated with persistent tissue toxicity and presence of myofibroblasts.
Topics: Actins; Animals; Collagen; Epoxy Resins; Fibrosis; Granulation Tissue; Image Processing, Computer-As | 2011 |
The histological effects of four endodontic sealers implanted in the oral mucosa: submucous injection versus implant in polyethylene tubes.
Topics: Administration, Buccal; Animals; Argyria; Barium Sulfate; Bismuth; Borates; Calcium Hydroxide; Drug | 2001 |